key: cord-0717950-dazfvy8c authors: Flores-Concha, Manuel; Oñate, Ángel A. title: Long Non-coding RNAs in the Regulation of the Immune Response and Trained Immunity date: 2020-07-24 journal: Front Genet DOI: 10.3389/fgene.2020.00718 sha: d67d252c85d01db1d13dc0dc1a9ee7730446416d doc_id: 717950 cord_uid: dazfvy8c nan One of the first and most notable examples of lncRNAs being involved in the regulation of the immune response is LincRNA-Cox2. In murine phagocytes stimulated by LPS, lincRNA-Cox2 significantly increases its expression in conjunction with the Cox-2 coding gene (ptgs2) (Carpenter et al., 2013) . Its nuclear interaction with various protein complexes like heterogeneous nuclear ribonucleoproteins (hnRNPs) A/B and A2/B1 (Carpenter et al., 2013) or non-fermentable switch/sucrose (SWI/SNF) , allows it to modulate the expression of different types of immune genes. In epithelial cells, lincRNA-Cox2 can block the expression of Il12b through the recruitment of Mi-2/nucleosome remodeling and deacetylase (Mi2/NuRD) complex to the promoter region of this gene (Tong et al., 2016) . LincRNA-Cox2 can exercise its regulatory functions beyond the boundaries of the nucleus, interacting directly with NF-κB, promoting its translocation and recruitment to promoter regions of the Nlrp3 and Asc genes, favoring the activation of inflammasome ( Figures 1A,F ) (Xue et al., 2019) . In human macrophages, another ptgs2-related lncRNA is PACER (P50-associated extragenic RNA COX-2). Its function is to hijack NF-κB1 subunits from the ptgs2 promoter, whose dimerization exerts a repressive effect. In this way, PACER facilitates the formation of NF-κB p65/p50 dimers, promoting the recruitment of p300 histone acetyltransferase to increase the accessibility of polymerase II pre-initiation complexes and guarantee the transcription of ptgs2 (Krawczyk and Emerson, 2014) . In murine resting myeloid cells, the transcription of several immunity-related genes (IRGs) is repressed by the expression of lincRNA-EPS (Atianand et al., 2016) . In bone-marrowderived macrophage (BMDM), both stimulation with LPS and infection with Listeria monocytogenes or Sendai virus, decrease the expression of this lncRNA. LincRNA-EPS is associated with hnRNPL to control nucleosomal positioning and chromatin accessibility. On the other hand, BMDMs obtained from lincRNA-EPS global knockout (KO) mice stimulated with LPS, have high levels of histone H3 trimethylation at lysine 4 (H3K4me3) in IRG promoters such as Il6, Il1a and Ccl5 typically associated with less dense nucleosome structures and active gene promoters assets (Wang et al., 2008) . Consistently, lincRNA-EPS deficient mice show higher expression of IRGs and greater susceptibility to septic shock when compared to wild type mice (Atianand et al., 2016; Mumbach et al., 2019) . Similarly, in nonstimulated human macrophages, lnc-13 interacts with hnRNPD and HDAC1 to suppress the transcription of immune genes ( Figure 1F ). An interesting fact is that several patients with celiac disease have a SNP in lnc-13, which prevents their interaction with HDAC1, increasing the expression of immune genes typical of the pathogenesis of this disease (Castellanos-Rubio et al., 2016) . As already mentioned, the interaction with transcription factors is also one of the strategies used by lncRNAs to exercise their modulating role. Lethe, a lncRNA expressed in response to TNF-α, exerts inflammatory regulatory functions through its interaction with the p65 subunit of the NF-κB transcription factor. Lethe transcription decreases the translocation of NF-κB and reduces the occupancy of the transcription factor in gene promoters regulated by NF-κB, within which the Lethe promoter is included, selfregulating its expression (Figures 1A,B) (Rapicavoli et al., 2013) . On the other hand, Lnc-DC regulates the differentiation and activation of dendritic cells in humans through its interaction with the transcription factor STAT3. This lncRNA is located in the cytoplasm to bind STAT3 and prevent its interaction with tyrosine phosphatase SHP1. This way, Lnc-DC keeps STAT3 in its active state, promoting the transcription of the program of genes that depend on it ( Figure 1C ; Wang et al., 2014) . A little more unknown but not less important is the role that lncRNAs play in the adaptive immune response. In humans, the differentiation of naive T lymphocytes to Th1 cells is controlled by lincRNA-MAF-4, which promotes the epigenetic silencing of MAF, a Th2 cell transcription factor. This lncRNA interacts with the LSD1 and EZH2 transcriptional repressors to place the H3K27me3 mark in the MAF promoter and suppresses its expression. The transcription of lincRNA-MAF-4 is exclusive to Th1 lymphocytes and it is not expressed in naive T cells or any other lymphoid lines (Ranzani et al., 2015) . On the other hand, Th2 lymphocytes specifically express a lncRNA, dependent on the Th2 "master regulator" GATA3, called LincR-Ccr2-5 ′ AS. Using a cell transfer model, it was shown that the decrease of LincR-Ccr2-5'AS using shRNA reduced the expression of Ccr1, Ccr3, Ccr2, and Ccr5, as well as the migration of Th2 effector cells to the lung of recipient mice (Hu et al., 2013) . In memory CD4 + T cells, the production of IL-2 in response to TCR signaling depends on the activation of the nuclear factor of activated T cells (NFAT) (Dienz et al., 2007) . This process can be regulated by NRON, a lncRNA that acts as a repressor, reducing NFAT levels in the nucleus. For this, NRON forms a complex with importin-beta1 and LRRK2, controlling the nucleocytoplasmic traffic of the NFAT (Figure 1D ; Willingham, 2005; Liu et al., 2011) . Traditionally, immunological memory has been a characteristic reserved only for adaptive immunity cells. However, several studies have shown that innate immune cells, are capable of generating a type of immune memory known as trained immunity or innate immune memory, in response to prolonged exposure of microbial components, thus being able to remember transcriptional responses and even inherit these memories to their progeny (Kleinnijenhuis et al., 2014; Kaufmann et al., 2018; Hole et al., 2019) . For instance, macrophages derived from trained hematopoietic stem cells (HSCs) are epigenetically reprogrammed and as a result can strongly express immune genes, increasing their ability to resolve an infection (Kaufmann et al., 2018; Mitroulis et al., 2018) . The development of this type of immune memory is accompanied by a stable accumulation of epigenetic marks on promoters of multiple immune genes allowing the characteristic priming of innate memory (Hole et al., 2019) . Although, it is not very clear how these marks are specifically accumulated on immune genes of trained cells, a recent study shows an active participation of a group of lncRNAs, called Immune-gene priming lncRNAs (IPLs), in the trained immunity . On the other hand, several immune genes that are distant from each other (from a one-dimensional perspective), but functionally related, can be spatially grouped into threedimensional chromatin microdomains called TAD (topologically associating domains), allowing their proximity and coregulation. Interestingly, many TADs integrate regions that encode lncRNAs, which are actively transcribed along with co-regulated genes (Fanucchi and Mhlanga, 2019; . In this context, IPLs are described as priming mediators of immune genes located in the same TAD that contains them. These lncRNAs are transcribed within these microdomains in order to direct histone modifying enzyme complexes to the set of co-regulated gene promoters, located in the same TAD, inducing their priming by epigenetic labeling. A good example is the upstream master lncRNA of the inflammatory chemokine locus (UMLILO). This IPL contacts the TAD of ELR+ CXCL chemokine genes (which contains the genes CXCL8, CXCL1, CXCL2 and CXCL3), recruiting the WDR5-MLL1 complex to direct it toward the promoters of the genes present in the TAD and catalyze the epigenetic priming, placing the H3K4me3 brand ( Figure 1E ). In mice, the TAD that groups these chemokines lacks an IPL, therefore the expression of these chemokines cannot be trained. Surprisingly, the insertion of UMLILO in the TAD of murine macrophage chemokines resulted in the training of Cxcl genes, providing strong evidence that lncRNA-mediated regulation is essential for the establishment of trained immunity . The study and identification of lncRNAs as active elements of gene regulation during the immune response adds a new level of complexity to its analysis. Its ability to dialogue with several proteins, allow them to control aspects ranging protein traffic to remodeling of the chromatin architecture. Despite the existence of several reviews that include the role of lncRNAs in immunity, we consider it important to highlight the role that they play in establishing trained immunity, a feature of the immune system that has even been recently considered as a tool for reducing susceptibility and severity of SARS-CoV2 infection (Netea et al., 2020) . Until now, the genetic approaches used by suggests that the "memory implantation, " require the local expression of the immune-gene priming lncRNA (IPL). If modulation on epigenetic regulators can affect a large number of genes and therefore exhibit unwanted effects, the use of lncRNAs could provide the specificity that is required. Understanding the factors that dictate the folding state of a given lncRNA, as well as the identification of structural motifs involved in the formation of multicomponent-complexes, may contribute to the design of new therapies. Based on the above, we infer that future advances in the study of lncRNAs could focus on their active participation in the establishment of trained immunity, which could be the beginning for the development of a new generation of immunomodulators, which point to the priming of innate immunity cells, making it more efficient against an immune reaction, as well as helping reverse immunotolerance states. Supplementing the knowledge about lncRNAs with the use of local expression tools (Xu et al., 2019) , could bring us closer to obtaining the precision we are looking for. All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication. Transcription of the non-coding RNA upperhand controls Hand2 expression and heart development A long noncoding RNA lincRNA-EPS Acts as a transcriptional brake to restrain inflammation Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses A long noncoding RNA mediates both activation and repression of immune response genes A long noncoding RNA associated with susceptibility to celiac disease Gene regulation in the immune system by long noncoding RNAs Stress-induced lncRNA LASTR fosters cancer cell fitness by regulating the activity of the U4/U6 recycling factor SART3 Accumulation of NFAT mediates IL-2 expression in memory, but not naïve, CD4+ T cells Emerging role of long noncoding RNAs as regulators of innate immune cell development and inflammatory gene expression B2 RNA binds directly to RNA polymerase II to repress transcript synthesis Immune genes are primed for robust transcription by proximal long noncoding RNAs located in nuclear compartments Lnc-ing trained immunity to chromatin architecture Induction of memory-like dendritic cell responses in vivo LincRNA-Cox2 promotes late inflammatory gene transcription in macrophages through modulating SWI/SNF-mediated chromatin remodeling Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation The expression of long noncoding RNA NEAT1 is reduced in schizophrenia and modulates oligodendrocytes transcription BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis BCG-induced trained immunity in NK cells: Role for non-specific protection to infection p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes Melanoma addiction to the long non-coding RNA SAMMSON The Firre locus produces a trans-acting RNA molecule that functions in hematopoiesis Association of long noncoding RNAs expression levels and their gene polymorphisms with systemic lupus erythematosus The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease Long non-coding RNAs (lncRNAs) and their transcriptional control of inflammatory responses The central role of RNA in human development and cognition Discovery and annotation of long noncoding RNAs Modulation of myelopoiesis progenitors is an integral component of trained immunity HiChIRP reveals RNA-associated chromosome conformation The NORAD lncRNA assembles a topoisomerase complex critical for genome stability Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4 A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β LncRNA SNHG5 regulates cell apoptosis and inflammation by miR-132/PTEN axis in COPD LincRNA-Cox2 modulates TNF-α-induced transcription of Il12b gene in intestinal epithelial cells through regulation of Mi-2/NuRDmediated epigenetic histone modifications The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation Combinatorial patterns of histone acetylations and methylations in the human genome A strategy for probing the function of noncoding RNAs finds a repressor of NFAT DGUOK-AS1 promotes cell proliferation in cervical cancer via acting as a ceRNA of miR-653-5p: DGUOK-AS1 promotes cervical cancer Gene activation by a CRISPR-assisted trans enhancer lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation inducible long noncoding RNA, regulates G1/S cell cycle progression by modulating IRES-dependent p27 translation LncRNA SNHG6 plays an oncogenic role in colorectal cancer and can be used as a prognostic biomarker for solid tumors This work was supported by Grant 1180122 from the Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT), Santiago, Chile. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Copyright © 2020 Flores-Concha and Oñate. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.